{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:31:31Z","timestamp":1787758291031,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>It is still debatable whether surgical staging of endometrial cancer (EC) should include sampling of peritoneal cytology (PC) and for what purpose this should be done. The aim of our study was to determine the significance of peritoneal cytology in EC and its association with other histological and clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a retrospective study that comprises of results from 357 patients with EC that were operated in our center in the previous nine years. Patients were divided into two groups: the first group with a positive and the second group with a negative PC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Malignant cells were found in the peritoneal cytology of 23 patients (6.4%), while 334 patients (93.6%) had negative PC. There was no significant difference in patients' age between the two groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.20). Peritoneal cytology was more prevalent in the non-endometrioid than the endometrioid subtype of EC (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.00). There was a significant statistical difference (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.00) in malignant PC in stages where cancer is confined to the uterus (International Federation of Gynecologists and Obstetricians (FIGO) stages I and II) compared with those where cancer has metastasized outside the uterus (stages III and IV). Most of the patients with malignant PC (69.6%) had high-grade disease (G3).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Malignant peritoneal cytology is associated with other negative prognostic factors in endometrial cancer (histological grade, FIGO stage, and non-endometrioid histological subtypes). Based on these findings, we encourage sampling of peritoneal washing in all EC patients and consider it mandatory in patients with non-endometrioid subtype, high-grade histology, and in advanced FIGO stage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joc.joc_53_22","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:07:08Z","timestamp":1666843628000},"page":"155-158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Association of Peritoneal Cytology with Other Prognostic Factors in Endometrial Cancer"],"prefix":"10.4103","volume":"39","author":[{"given":"Slobodan","family":"Maricic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljosa","family":"Mandic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Vasiljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Gutic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemanja","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Maksimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240905","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-3-20240905","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"R3-3-20240905","first-page":"125","article-title":"Announcement FIGO stages: 1988 revisions","volume":"35","author":"Creasman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R4-3-20240905","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"R5-3-20240905","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","volume":"91","author":"Tebeu","year":"2004","journal-title":"Br J Cancer"},{"key":"R6-3-20240905","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br J Cancer"},{"key":"R7-3-20240905","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"key":"R8-3-20240905","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R9-3-20240905","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"key":"R10-3-20240905","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: Matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R11-3-20240905","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/gyno.1997.4858","article-title":"The significance of peritoneal cytology in uterine cervix and endometrial cancer","volume":"67","author":"Kashimura","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R12-3-20240905","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2017.03.017","article-title":"Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology\/Gynecologic Oncology Group study on GOG-210 protocol","volume":"145","author":"Creasman","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R13-3-20240905","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R14-3-20240905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2020.07.010","article-title":"Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer","volume":"159","author":"Matsuo","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R15-3-20240905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2021.01.007","article-title":"Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer","volume":"161","author":"Takenaka","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R16-3-20240905","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.suronc.2019.01.001","article-title":"The prognostic significance of positive peritoneal cytology in endometrial cancer and its correlations with L1-CAM biomarker","volume":"28","author":"Vizza","year":"2019","journal-title":"Surg Oncol"},{"key":"R17-3-20240905","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyw063","article-title":"Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: A systematic review and meta-analysis","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn J Clin Oncol"}],"container-title":["Journal of Cytology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joc.joc_53_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:12:16Z","timestamp":1787757136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joc.joc_53_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/joc.joc_53_22","relation":{},"ISSN":["0970-9371"],"issn-type":[{"value":"0970-9371","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}